C. A. Longui, Glucocorticoid therapy: minimizing side effects, J Pediatr, vol.83, pp.163-77, 2007.

D. Liu, A. A. Ward, L. Krishnamoorthy, P. Mandelcorn, E. D. Leigh et al., A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy, Allergy Asthma Clin Immunol, vol.9, p.30, 2013.

A. Vegiopoulos, S. Herzig, and . Glucocorticoids, metabolism and metabolic diseases, Mol Cell Endocrinol, vol.275, pp.43-61, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00531932

M. J. Lee, P. Pramyothin, K. Karastergiou, and S. K. Fried, Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity, Biochim Biophys Acta, vol.1842, pp.473-81, 2014.

C. J. Petersons, B. L. Mangelsdorf, A. B. Jenkins, A. Poljak, M. D. Smith et al., Effects of low-dose prednisolone on hepatic and peripheral insulin sensitivity, insulin secretion, and abdominal adiposity in patients with inflammatory rheumatologic disease, Diabetes Care, vol.36, pp.2822-2831, 2013.

I. N. Karatsoreos, S. M. Bhagat, N. P. Bowles, Z. M. Weil, D. W. Pfaff et al., Endocrine and physiological changes in response to chronic corticosterone: a potential model of the metabolic syndrome in mouse, Endocrinology, vol.151, pp.2117-2144, 2010.

S. A. Kinlein, Z. Shahanoor, R. D. Romeo, and I. N. Karatsoreos, Chronic corticosterone treatment during adolescence has significant effects on metabolism and skeletal development in male C57BL6/N mice, Endocrinology, vol.158, pp.2239-54, 2017.

Y. Shpilberg, J. L. Beaudry, D. Souza, A. Campbell, J. E. Peckett et al., A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding, Dis Model Mech, vol.5, pp.671-80, 2012.

I. Luijten, K. Brooks, N. Boulet, I. G. Shabalina, A. Jaiprakash et al., Glucocorticoid-induced obesity develops independently of UCP1, Cell Rep, vol.27, pp.1686-98, 2019.

A. Rafacho, H. Ortsater, A. Nadal, and I. Quesada, Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes, J Endocrinol, vol.223, pp.49-62, 2014.

S. Karlsson, B. Ostlund, U. Myrsen-axcrona, F. Sundler, and B. Ahren, Beta cell adaptation to dexamethasone-induced insulin resistance in rats involves increased glucose responsiveness but not glucose effectiveness, Pancreas, vol.22, pp.148-56, 2001.

K. Briot and C. Roux, Glucocorticoid-induced osteoporosis, RMD Open, vol.1, p.14, 2015.

M. Tada, K. Inui, Y. Sugioka, K. Mamoto, T. Okano et al., Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study, Osteoporos Int, vol.27, pp.729-764, 2016.

T. C. Brennan-speranza, H. Henneicke, S. J. Gasparini, K. I. Blankenstein, U. Heinevetter et al., Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism, J Clin Invest, vol.122, pp.4172-89, 2012.

N. K. Lee, H. Sowa, E. Hinoi, M. Ferron, J. D. Ahn et al., Endocrine regulation of energy metabolism by the skeleton, Cell, vol.130, pp.456-69, 2007.

M. Ryo, T. Nakamura, S. Kihara, M. Kumada, S. Shibazaki et al., Adiponectin as a biomarker of the metabolic syndrome, Circ J, vol.68, pp.975-81, 2004.

K. Maeda, Role of adiponectin and adipocyte fatty acid binding protein in the metabolic syndrome, Diabetes Res Clin Pract, vol.77, pp.17-22, 2007.

M. S. Rasmussen, A. S. Lihn, S. B. Pedersen, J. M. Bruun, M. Rasmussen et al., Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, And Fat Depots Obesity, vol.14, pp.28-35, 2006.

Y. Y. Lin, C. Y. Chen, T. Y. Chuang, Y. Lin, H. Y. Liu et al., Adiponectin receptor 1 regulates bone formation and osteoblast differentiation by GSK-3beta/beta-catenin signaling in mice, Bone, vol.64, pp.147-54, 2014.

J. Thundyil, D. Pavlovski, C. G. Sobey, and T. V. Arumugam, Adiponectin receptor signalling in the brain, Br J Pharmacol, vol.165, pp.313-340, 2012.

S. Moghadam-kia and V. P. Werth, Prevention and treatment of systemic glucocorticoid side effects, Int J Dermatol, vol.49, pp.239-287, 2010.

M. Okada-iwabu, T. Yamauchi, M. Iwabu, T. Honma, K. Hamagami et al., A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity, Nature, vol.503, pp.493-502, 2013.

S. Nicolas, D. Debayle, C. Bechade, L. Maroteaux, A. S. Gay et al., Adiporon, an adiponectin receptor agonist acts as an antidepressant and metabolic regulator in a mouse model of depression, Transl Psychiatry, vol.8, p.159, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01868962

G. E. Beranger, D. F. Pisani, J. Castel, M. Djedaini, S. Battaglia et al., Oxytocin reverses ovariectomy-induced osteopenia and body fat gain, Endocrinology, vol.155, pp.1340-52, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00968717

J. Chabry, S. Nicolas, J. Cazareth, E. Murris, A. Guyon et al., Enriched environment decreases microglia and brain macrophages inflammatory phenotypes through adiponectin-dependent mechanisms: relevance to depressive-like behavior, Brain Behav Immun, vol.50, pp.275-87, 2015.

C. M. Apovian, S. Bigornia, M. Mott, M. R. Meyers, J. Ulloor et al., Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects, Arterioscler Thromb Vasc Biol, vol.28, pp.1654-1663, 2008.

M. S. Cooper, M. J. Seibel, H. Zhou, and . Glucocorticoids, bone and energy metabolism. Bone, vol.82, pp.64-72, 2016.

D. Blackburn, J. Hux, and M. Mamdani, Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly, J Gen Intern Med, vol.17, pp.717-737, 2002.

A. L. Buchman, Side effects of corticosteroid therapy, J Clin Gastroenterol, vol.33, pp.289-94, 2001.

C. Scaroni, M. Zilio, M. Foti, and M. Boscaro, Glucose metabolism abnormalities in cushing syndrome: from molecular basis to clinical management, Endocr Rev, vol.38, pp.189-219, 2017.

A. O. Protzek, L. F. Rezende, J. M. Costa-junior, S. M. Ferreira, A. P. Cappelli et al., Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme, J Steroid Biochem Mol Biol, vol.155, pp.1-8, 2016.

V. Pellegrinelli, S. Carobbio, and A. Vidal-puig, Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues, Diabetologia, vol.59, pp.1075-88, 2016.

J. H. Stern, J. M. Rutkowski, and P. E. Scherer, Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk, Cell Metab, vol.23, pp.770-84, 2016.

K. Oshima, A. Nampei, M. Matsuda, M. Iwaki, A. Fukuhara et al., Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast, Biochem Biophys Res Commun, vol.331, pp.520-526, 2005.

D. Kajimura, H. W. Lee, K. J. Riley, E. Arteaga-solis, M. Ferron et al., Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1, Cell Metab, vol.17, pp.901-916, 2013.